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The flux of arginine after ischemia-reperfusion in the rat The amino acid arginine is important in the function of
kidney. lymphocytes as it improves the cellular immune responses
Background. Renal arginine synthesis is regulated by argi- and nitrogen balance when administered to animals andnine plasma levels. The amino acid arginine is synthesized in
humans [1, 2]. Furthermore, it is the sole precursor aminothe proximal tubule of the kidney. Renal ischemia reperfusion
acid in the generation of the immunity-enhancing and(I-R) injury as seen after shock, trauma and major vascular
surgery, leading to acute tubular necrosis, might reduce argi- vasodilating agent nitric oxide (NO) by nitric oxide syn-
nine production. thase (NOS) [3].
Methods. Wistar rats received either bovine liver arginase The predominant site of arginine production is the kid-(ASE), to lower arginine plasma levels, or saline (SAL). Fol-
ney, which synthesizes arginine from circulating citrul-lowing the ASE or SAL infusion, rats were randomized to
line [4, 5]. This metabolic route is the most importantreceive a renal artery clamp for 70 minutes, followed by 150
minutes of reperfusion. Renal arteriovenous blood samples source of circulating arginine plasma levels [6]. Within
were measured and plasma flow was calculated in the I-R the kidney arginine is produced in the proximal tubulus
kidney (SAL/I-R and ASE/I-R) and the contralateral kidney
[7, 8]. Recently, we have shown that low arginine plasma(SAL/C-L and ASE/C-L) in order to determine renal arginine
levels are the drive for this renal arginine production,metabolism.
Results. Arginase infusion resulted in lower arginine plasma while at physiological plasma levels there is almost no
levels compared to SAL treatment (SAL/I-R vs. ASE/I-R, P arginine production by the normal kidney [9]. We hy-
0.005, and SAL/C-L vs. ASE/C-L, P  0.005). Renal plasma pothesized that renal ischemia-reperfusion (I-R) injury,
flow was similar for all groups. The kidney switched from ar-
leading to tubular necrosis, might affect arginine produc-ginine production into arginine uptake after ischemia reper-
tion by the kidney at low arginine plasma levels.fusion (SAL/I-R vs. SAL/C-L, P  0.01, and ASE/I-R vs.
ASE/C-L, P  0.01). Renal uptake of glutamine and citrulline In clinical practice, low arginine plasma levels are mea-
increased after ischemia reperfusion (SAL/I-R vs. SAL/C-L sured in patients with severe trauma, shock [10, 11],
and ASE/I-R vs. ASE/C-L, both P  0.01). Histopathological and major surgery, especially suprarenal aorta aneurysmslices of the kidney showed significantly higher counts of hyp-
repair surgery [12], conditions that severely affect theerchromasia, pyknosis, nuclear fragmentation and mitoses in
kidneys.individual kidney cells after ischemia reperfusion.
Conclusion. Decreased renal arginine production is ob- The present study was designed to investigate the pro-
served with unilateral ischemia-reperfusion, and this change duction of arginine after ischemia-reperfusion. Arginase,
in arginine flux could contribute to or slow the recovery from the final enzyme of the urea cycle converting argininethe low plasma levels of arginine seen in conditions like trauma,
into urea and ornithine in a 1:1 ratio [13], was used toshock, or after vascular procedures.
evaluate the effect of low arginine plasma levels after
renal ischemia-reperfusion injury.
METHODS
Animal model
Key words: I-R injury, kidney, amino acids, unilateral ischemia-reper-
fusion, trauma, shock, vascular procedures, tubular necrosis. Forty immature male Wistar rats (Harlan CPB, Zeist,
The Netherlands), weighing 250 to 275 g, were used forReceived for publication December 28, 2000
this study (Fig. 1). The animals were maintained in accor-and in revised form February 12, 2002
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supine position on a heating pad that maintained a rectal
temperature at 37C. The trachea was intubated with
a small piece of polyethylene tubing (PE-240; Fisher
Scientific, Springfield, NJ, USA) to facilitate breathing.
The right carotid artery, right jugular vein and right
femoral artery were cannulated using PE-50 tubing. Fol-
lowing these procedures, rats were allowed to stabilize
for 30 minutes prior to the start of the arginase infusion.
At the end of the experiment (at 270 min) an intraven-
tricular injection of 103Ru labeled microspheres was given
to assess organ blood flows as previously described [14].
Immediately following the microsphere procedure the
abdomen was re-opened and blood samples (0.4 mL)Fig. 1. Diagram of the experimental model. Abbreviations are: SAL,
saline-treated; I-R, ischemia-reperfused kidney; C-L, contralateral kid- were drawn from the left renal vein and aorta as earlier
ney; ASE, arginase-treated; min, minutes. Note that all data presented described in detail [15]. The rat anatomy allows a farin the Results section were obtained at the end of the experiment (t 
easier puncture of the left renal vein, because of the270 min).
greater length, compared to the right renal vein. After
blood sampling, rats were killed by an intra-arterial injec-
tion of pentobarbital sodium (100 mg · kg1). After veri-
No. NIH, 85-23, Revised 1985, Office of Science and fication of the position of the left ventricular catheter
Health Reports, DRR/NIH, Bethesda, MD 20205). After and inspection of the interventricular septum, the organ
admission, rats were allowed to adapt to the laboratory of interest, the left kidney, was removed for measure-
environment for five days. Animals had free access to ments of radioactivity. Renal blood flow (F) was com-
food and water and were subjected to a 12:12 hour puted according to the “reference organ” technique [16].
light:dark cycle. On day 6, after an overnight fast, the Briefly, the reference blood sample was obtained from
rats first underwent a surgical procedure as described in the left femoral artery at a rate of 0.4 mL · min1 during
the next section, after which rats were randomly assigned 120 seconds starting 5 seconds before injection of micro-
to receive (at t  0 min; Fig. 1) an intravenous infusion spheres, and the radioactivity of the blood sample was
(jugular vein, 1.5 mL NaCl 0.9%; SAL, N 20) or 1.5 mL counted. Plasma flow was computed by correction for
NaCl 0.9% of an arginase solution (3000 IU; ASE, N  hematocrit by the equation: plasma flow blood flow
20) over a 20 minute period through an infusion pump.
(1  hematocrit) (Microhematocrit reader; Hawskley
Ten minutes after the SAL or ASE infusion (at t  30
and Sons, London, UK).min), the abdomen was opened by a mid-line laparot-
omy. The left renal artery was exposed for both the SAL/ Plasma amino acid and chemical analysis
I-R (N  10) and ASE/I-R (N  10) groups, whereas
Blood samples were immediately placed on ice, andthe right renal artery was exposed for both the SAL/
centrifuged at 3000 rpm for 10 minutes at 4C. (SorvalC-L and ASE/C-L (N 10) groups. Between 50 and 120
GLC 2 centrifuge; Sorvall Operations; DuPont, Newton,minutes, the left renal (SAL/I-R and ASE/I-R groups) or
MA, USA). For amino acid analysis the heparinizedright renal (SAL/C-L and ASE/C-L groups) artery was
plasma samples were deproteinized with sulfosalicylicoccluded for 70 minutes. Thereafter, the clamp was re-
acid (4 mg · 100L1), immediately put in liquid nitrogenmoved to allow a reperfusion of the renal vasculature
and stored at70C prior to analysis. Additional plasmafor a period of 150 minutes. At the end of the experiment
samples were stored at70C for determination of blood(at 270 min) blood flow and arteriovenous amino acid
chemistry.differences of the left kidney were determined for all
Amino acids were determined by high performancegroups. The commercially available enzyme arginase
liquid chromatography as previously described [17]. Cre-(ASE) was obtained from Sigma Aldrich (Zwijndrecht,
atinine and urea were determined in arterial plasma sam-The Netherlands; E.C. 3.5.3.1, yellow powder, activity
ples using an automated analyzer (Type H 737; Hitachi,130 IU/mg).
Tokyo, Japan).
Hemodynamic measurements and blood sampling
CalculationsKidney blood flow measurements were performed at
Kidney uptake or release of amino acids (flux) wasthe end of the experiment (at 270 min). The renal blood
calculated from the plasma flows and arteriovenousflow was measured using radiolabeled microspheres as
amino acid concentration differences for the left kidney.previously described [14]. The animals were anesthetized
using ketamine HCl (50 mg · kg1 i.p.) and placed in the The amino acid flux for the kidney was calculated by
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the product of left renal plasma flow and the arterio- determined after enzymatic conversion of nitrate to ni-
trite by a colorimetric method according to Griess, us-renal venous concentration difference.
Fluxes are expressed as nmol · 100 g BW1 · min1, ing the Aspergillus nitrate reductase (Boerhinger, Mann-
heim, Germany).where BW represents body weight. Negative values rep-
resent release and positive values an uptake by the kid-
Statistical analysesney. Each parameter was calculated for each individual
animal using its individual amino acid concentrations Results are expressed as means SEM. The statistical
analysis was performed by analysis of variance (two-wayand plasma flows.
ANOVA). The analysis was performed by a commercial
Histopathological examination statistical package (Stat-View; Abacus Concepts, Inc.,
Berkeley, CA, USA) on a Macintosh computer (AppleHistopathological examinations of the kidneys were
performed in a separate study [N  24, SAL/I-R and Computer, Inc., Berkeley, CA, USA). The detected dif-
ferences between groups were tested for significance us-SAL/C-L (N  8); ASE/I-R (N  8); and ASE/ C-L)
(N 8)]. The animals used in this separate study fulfilled ing the Mann-Whitney U-test. Significance was accepted
at P  0.05.the same surgical protocol as described before, with the
exception of blood flow assessment with radiolabeled
microspheres. After the rats were killed the kidneys were
RESULTS
taken out and put on 10% buffered formaldehyde and
Blood chemistryembedded on paraffin. Sections were cut and stained
with routine hematoxylin and eosin (H&E) stain. Renal Directly after the microsphere injection (at t  270
min; study design in Fig. 1) the abdomen was opened andpathology associated with acute tubular necrosis was
evaluated at microscopic level. All slides were judged in blood samples were drawn. In general, no differences
between the SAL/I-R (saline/ischemia-reperfusion) anda blinded fashion by the same investigator. Histopatho-
logic grades were assigned to each kidney specimen as: SAL/C-L (saline/contralateral) groups and between the
ASE/I-R (arginase/ischemia-reperfusion) and ASE/C-L0  normal; 1  mitoses and necrosis of individual cells;
2  necrosis of all cells in adjacent proximal convoluted (arginase/contralateral) groups were expected because
of the assumption that ischemia followed by reperfusiontubulus, with survival of surrounding tubulus; 3 necro-
sis confined to the distal third of the proximal convoluted of the left or the right kidney have similar impact on the
systemic parameters (Table 1). Indeed, there were no dif-tubule; 4  necrosis affecting all three segments of the
proximal convoluted tubule [18]. Due to the early point ferences. More importantly there were no differences in
hematocrit, global parameters of kidney function andin time on which kidneys were harvested, all “clamped”
kidneys (SAL/I-R and ASE/I-R) showed grade 1 damage acid-base homeostasis between SAL and ASE treatment.
and all control kidneys showed grade 0 damage. There-
Plasma flowfore, the grading method was refined by counting hyp-
erchromasia, pyknosis, nuclear fragmentation and mito- Renal plasma flows are expressed in mL/min and are
shown in Table 2. Renal plasma flow did not differ be-ses of individual cells in proximal convoluted tubules in
each slide. In each kidney specimen five high power fields tween the groups at 270 minutes.
(amplification 400) in the outer cortex and five high
Amino acid analysispower fields (amplification 400) in the inner cortex
were examined, and hyperchromasia, pyknosis, nuclear Arginine plasma levels at 270 minutes are shown in
Table 3. Arginase infusion resulted in lower arterial ar-fragmentation and mitoses of individual cells were
counted in 3 tubules per field. ginine plasma levels (for both ASE/I-R vs. SAL/I-R and
ASE/C-L vs. SAL/C-L, P  0.005) and lower renal ve-
Nitrate assay nous arginine plasma levels (ASE/I-R vs. SAL/I-R and
for ASE/C-L vs. SAL/C-L, P  0.01). Renal venousNitrite plus nitrate was determined in plasma and
urine, sampled at the end (at 270 min) of a separate arginine plasma levels were higher in the SAL/C-L and
ASE/C-L groups when compared to SAL/I-R and ASE/experiment in which ischemia (70 min) and reperfusion
(150 min) were performed in three different groups (N I-R groups (for both groups P  0.01), respectively,
which was consistent with the concept that decreased12, four subjects in each of the three groups). The effect
of ischemia reperfusion of one and two kidneys and a arginine plasma levels produce increased renal arginine
production.control group without ischemia reperfusion injury, on
nitrate plasma and urine levels were studied. Plasma Renal venous citrulline, glutamine and glutamate
plasma levels were lower in the SAL/C-L group whensamples (0.1 mL) were diluted with 0.5 mL phosphate
buffer (35 mmol/L, pH 7.5). Urine samples were diluted compared to SAL/I-R (P  0.01, P  0.01 and P  0.01,
respectively) and in the ASE/C-L group when compared20 times with bidistilled water. Nitrite and nitrate were
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Table 1. Blood chemistry
SAL/I-R SAL/C-L ASE/I-R ASE/C-L
Hct % 0.500.01 0.490.01 0.500.02 0.500.01
Creatinine lmol/L 67.02.1 68.92.1 67.32.2 69.42.0
Urea mmol/L 8.80.6 8.21.0 9.00.7 7.20.6
pH 7.440.03 7.430.06 7.420.03 7.440.05
HCO3 mmol/L 16.661.08 17.541.43 17.061.28 17.982.02
Lactate mmol/L 1.960.23 2.020.32 2.340.29 2.580.26
Results are expressed as means  SEM. Note that no differences between the groups were detected. Abbreviations are: SAL, saline-treated; I-R, ischemic-
reperfusion; C-L, contralateral kidney; Hct, hematocrit.
Table 3. Amino acid plasma levelsTable 2. Renal plasma flow
SAL/I-R SAL/C-L ASE/I-R ASE/C-L SAL/I-R SAL/C-L ASE/I-R ASE/C-L
ArginineRenal flow 2.250.28 2.740.25 2.110.17 2.580.14
A lmol/L 103.25.5 99.84.9 44.76.3a 42.46.8bResults are expressed in mL · min1 as means  SEM.
Rv lmol/L 69.73.1 104.76.5d 31.44.6e 57.26.7cf
Citrulline
A lmol/L 62.73.0 63.55.5 64.63.6 66.72.3
Rv lmol/L 50.73.0 39.94.5g 53.13.2 34.41.5j
Glutamineto the ASE/I-R (P  0.005, P  0.01 and P  0.01,
A lmol/L 780.634.4 793.541.0 773.431.7 796.443.6respectively).
Rv lmol/L 503.630.0 414.826.8h 493.025.3 402.926.5k
Ornithine arterial plasma levels were measured to Glutamate
A lmol/L 42.76.9 40.18.9 42.44.8 41.33.7evaluate the ASE infusion, as arginase converts arginine
Rv lmol/L 108.313.5 44.87.8i 92.87.2 46.06.6linto ornithine in a 1:1 ratio. Arterial ornithine plasma
Ornithine
levels in the SAL/C-L– and in the SAL/I-R–treated A lmol/L 40.04.6 42.23.7 98.84.1m 91.54.6o
Rv lmol/L 29.63.8 40.13.1q 60.83.3n 73.83.1prgroups were similar (40.0  4.6 and 42.2  3.7 mol/L,
respectively). Arterial plasma levels of ornithine in the Results are expressed as means SEM. Significances are indicated as follows:
Arginine; for ASE/I-R versus SAL/I-R; a P  0.005; eP  0.01, for ASE/C-LASE/C-L and the ASE/I-R treated groups were similar
versus SAL/C-L; b P  0.005, c P  0.01, for SAL/C-L versus SAL/I-R; d P 
(98.8 4.1 and 91.5 4.6, respectively), and these levels 0.01 and for ASE/C-L versus ASE/I-R; f P  0.01; citrulline, glutamine and
glutamate; for SAL/C-L versus SAL/I-R; ghi P  0.01. For ASE/C-L versus ASE/were significantly higher compared to saline treated ani-
I-R jl P  0.01, k P  0.005, ornithine; for ASE/I-R versus SAL/I-R; mn P  0.005,
mals (SAL/C-L vs. ASE/C-L and SAL/I-R vs. ASE/I-R, for ASE/C-L versus SAL/C-L; o P  0.005, p P  0.01; for SAL/C-L versus SAL/
I-R; q P  0.05, for ASE/C-L versus ASE/I-R; r P  0.05.P 0.005 for both groups). Renal ornithine plasma levels
were higher in the ASE treated animals compared to
the saline treated animals (ASE/SAL versus SAL/C-L,
P  0.01, and for ASE/I-R vs. SAL/I-R, P  0.005). 0.005). Glutamate was released from the kidneys (Fig.
Furthermore, higher ornithine plasma levels were de- 2D). Differences were measured between SAL/C-L ver-
tected in the SAL/C-L and ASE/C-L treated animals
sus SAL/I-R and ASE/C-L versus ASE/I-R (P  0.01
compared to SAL/I-R and ASE/I-R treated animals (P
for both groups).0.05 for both groups, respectively).
Renal ornithine handling is shown in Figure 2E.
Higher uptake of ornithine was seen after arginaseKidney amino acid handling
infusion (ASE/I-R vs. SAL/I-R group and ASE/C-L vs.The key organ in arginine production is the kidney.
SAL/C-L group; both P  0.01). Furthermore, higherFigure 2A shows the flux of arginine. Ischemia-reperfu-
renal ornithine uptake was measured after ischemia re-sion of the kidney resulted in an uptake of arginine,
perfusion (SAL/I-R and ASE/I-R groups when com-while the contralateral kidneys were still able to release
pared to the SAL/C-L and ASE/C-L groups; P  0.05,arginine (SAL/C-L vs. SAL/I-R and ASE/C-L vs. ASE/
respectively).I-R; for both groups P  0.01, respectively). Renal ar-
ginine release was higher in the ASE/C-L compared to
Histopathologic examinationsthe SAL/C-L group (P  0.05), while renal arginine
The results of the histopathological examinations areuptake was higher in the SAL/I-R compared to the ASE/
shown in Table 4. Ischemia-reperfusion of the kidneyI-R treated group (P 0.01). Citrulline uptake (Fig. 1B)
resulted in significantly higher hyperchromasia, pykno-was higher in the SAL/C-L and ASE/C-L groups com-
sis, nuclear fragmentation and mitoses when comparedpared to SAL/I-R and ASE/I-R groups (for both groups
to contralateral kidneys. Note that arginase infusion re-P 0.01). A similar pattern was detected for renal gluta-
sulted in similar histopathological scores when comparedmine metabolism (Fig. 2C), for SAL/C-L versus SAL/
I-R (P  0.01), and for ASE/C-L versus ASE/I-R (P  to saline infusion (Fig. 3).
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Fig. 2. Kidney fluxes are presented in nmol
100 g BW1 · min1 and data are means 
SEM for all groups. BW is body weight. Sym-
bols are: () SAL/I-R; ( ) SAL/C-L; ( )
ASE/I-R; () ASE-C-L. Abbreviations are:
SAL, saline-treated; I-R, ischemia-reperfused
kidney; C-L, contralateral kidney; ASE, argi-
nase-treated. (A) Arginine; *P  0.005 for
both SAL/C-L versus SAL/I-R and for ASE/
C-L versus ASE/I-R; **P 0.01 for ASE/C-L
versus ASE/I-R; and ***P  0.05 for ASE/
C-L versus SAL/C-L. (B) Citrulline; *P 0.01
both for SAL/C-L versus SAL/I-R and ASE/
C-L versus ASE/I-R. (C ) Glutamine; *P 
0.01 both for SAL/C-L versus SAL/I-R and
for ASE/C-L versus ASE/I-R. (D) Glutamate;
*P  0.01 for both SAL/C-L versus SAL/I-R
and ASE/C-L versus ASE/I-R. (E). Ornithine;
*P  0.01 for both SAL/C-L versus SAL/I-R
and ASE/C-L versus ASE/I-R.
Table 4. Renal histopathological examination DISCUSSION
SAL/I-R SAL/C-L ASE/I-R ASE/C-L The present study shows that after renal ischemia fol-
lowed by reperfusion, the kidney switched from arginineHyperchromasia 95.612.2 35.38.8a 66.410.8 28.73.4b
Pyknosis 268.018.3 8.91.4c 233.921.3 5.31.16d release into arginine uptake.
Nuclear fragment 0.50.15 0.080.07e 1.00.37 0.030.02f The rationale behind this study is that, in clinical prac-Mitoses 0.580.19 00g 0.550.24 00h
tice, low arginine plasma levels are measured in patients
Results are expressed as means  SEM. Significances were indicated as fol-
with severe trauma, shock [10, 11], and surgery, espe-lows: Hyperchromasia, pyknosis, nuclear fragmentation and mitoses: for SAL/
C-L versus SAL/I-R; a P  0.001, c P  0.005, e P  0.05 and g P  0.01, for ASE/ cially suprarenal aorta aneurysm repair surgery [12], con-
C-L versus ASE/I-R; b P  0.005, d P  0.0001, f P  0.01, h P  0.05.
ditions that severely affect the kidneys.
Arginase is an intracellular hepatic enzyme that con-
verts arginine into ornithine and urea, in the final step
Nitrate plasma and urine levels of the urea cycle. The enzyme arginase was administered
The results of nitrate measurements are given in in a dose (3000 IU per rat in a 20 min period; Fig. 1)
Table 5. There was a significant increase in nitrate con- that resulted directly in undetectable plasma levels of
centration in urine after ischemia reperfusion of one arginine [19]. Four hours later (at 270 min), at the end
kidney. Ischemia-reperfusion of both kidneys further of the experiment arginine plasma levels were partially
raised the urine nitrate concentrations. There were no restored to 50% of physiological values (Table 4). These
differences between the arterial and renal venous plasma reductions in arginine plasma levels do correspond with
pathophysiological states like severe trauma, shock andlevels within and between the three groups.
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Fig. 3. Examples of transverse kidney sec-
tions. Sections were cut and stained with rou-
tine H&E, magnification 400. In panels A
and B there is tubular damage. while no dis-
cernable changes are found in the contralat-
eral kidney in arginase (C ) and saline-treated
(D) animals at the end of the experiment.
Table 5. Nitrate plasma and urine levels convoluted tubules showed a clear increase of hyper-
chromasia, pyknosis, nuclear fragmentation and mitosis0 Kidney I-R 1 Kidney I-R 2 Kidneys I-R
in the ischemia-reperfusion groups (Fig. 3 and Table 4).A lmol/L 5.61.2 6.91.8 8.82.4
Rv lmol/L 5.41.3 6.31.1 7.91.9 These parameters are indicators of presence and severity
Bl lmol/L 73.14.1 242.626.6a 434.048.9bc of acute tubular necrosis as seen in acute renal failure.
Results are expressed as means SEM. A, Rv and Bl correspond with plasma Ornithine and urea plasma levels were measured to
levels of nitrate in the aorta, renal vein and bladder, respectively. Groups were
evaluate arginine conversion as a result of the arginasedivided in three groups with 0, 1 and 2 ischemia reperfused injured kidneys.
Significances are indicated as follows: 1 versus 0 kidney I-R; a P  0.01; 2 versus infusion (Tables 1 and 3). Arginase infusion (ASE/I-R
1 kidney I-R, b P  0.05; 2 versus 0 kidney I-R, c P  0.001.
and ASE/C-L) increased arterial ornithine plasma levels
compared to saline infusion (SAL/I-R and SAL/C-L),
indicating that the infused enzyme arginase was active.
Urea plasma levels were similar for all groups and thismajor surgery, where similar reductions in arginine
plasma levels have been measured [10–12], and for this was surprising because a similar increase as in ornithine
plasma levels was expected. Arginase converts argininereason the time point of 270 minutes was chosen to study
arginine fluxes. The dose of arginase was in the range as in ornithine and urea in a 1:1 ratio. Although urea metab-
olism was not studied, the increase in urea metabolismused by others who showed similar reductions in arginine
plasma levels [20–22]. We have previously shown that a may have resulted in a higher renal clearance, probably
by the contralateral kidney, maintaining steady plasmareduction of arginine plasma levels by 50% result in a
renal arginine synthesis of 30 nmol/100 g BW · min, urea concentrations. An alternative explanation could be
the much higher pool size and relatively slower fractionalwhile at normal arginine plasma levels there is almost
no production of arginine (3 nmol/100 g BW · min) turnover rate of urea than ornithine.
The renal release of arginine in ASE/C-L group was[9]. This model of arginase infusion gave us an excellent
opportunity to study the effects renal ischemia-reperfu- higher compared to the SAL/C-L group, indicating that
arginine plasma levels act as the drive for this renalsion have on renal arginine handling in the unilateral
and contralateral kidney both at normal and reduced release, as previously shown [9]. In that experiment,
healthy kidneys at low and normal arginine plasma levelsarginine plasma levels.
Because in all rats either the left (SAL/I-R and ASE/ had a similar extent of arginine release as the ASE/C-L
and the SAL/C-L groups, respectively [9], meaning thatI-R) or the right (SAL/C-L and ASE/C-L) kidney was
clamped, no differences in systemic parameters were kidney arginine synthesizing capacity is not compro-
mised due to I-R on the other kidney. Interestingly, afterexpected and measured between the groups (Table 1).
Renal histopathological examinations of the proximal ischemia-reperfusion (SAL/I-R) and to a lesser extent
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in the ASE/I-R group, the kidney switched from arginine dimethylarginine, reach plasma levels in proportion to
release to the uptake of arginine. Since the renal plasma serum creatinine in renal failure [30]. Plasma concentra-
flow was similar for all groups, the detected differences tions of arginine are reduced in patients with renal failure
in fluxes were consequently derived from arteriovenous [31], suggesting that urinary excretion of arginine plays
amino acid differences. Indeed, the arginine arterio-renal a minor role in arginine elimination [32]. Therefore, the
venous differences were positive for the ischemia-reper- uptake of arginine by kidney might be a mechanism to
fusion groups (SAL/I-R, ASE/I-R), and negative for the counteract or at least compete with the accumulated
contralateral kidneys (SAL/C-L, ASE/C-L), meaning plasma and organ levels of methylarginine, for the active
uptake and release of arginine by the kidney, respec- sites of NOS.
tively. Obviously, diminished renal arginine release was The intriguing question is why the kidney takes up
expected after ischemia reperfusion, since arginine is arginine after ischemia followed by reperfusion. Huk et
synthesized in the proximal tubulus of the kidney [23, 24]. al showed that arginine treatment produces a protective
Dhanakoti et al showed high activities of the enzyme effect after ischemia-reperfusion of skeletal muscle, by
argininosuccinate lyase and argininosuccinate synthetase preventing NO deficiency due to its consumption by the
in the proximal tubulus [25]. For arginine synthesis, both superoxide radical O2 [33]. The explanation was that
enzyme activities are required [26]. In this reaction, lac- below a certain critical level of arginine, NOS simply
tate serves as an energy source, since adenosine triphos- starts to produce O2 from its other substrate O2. Due
phate (ATP) is required for the argininosuccinate syn- to the extensive NO production during ischemia-reperfu-
thetase reaction. Ischemia-reperfusion resulted in severe sion, transport of arginine from the cytosol to the active
damage to the proximal tubulus (Table 4) and most likely site of NOS does not appear to be fast enough for a con-
to the highly enzyme-dependent, energy-requiring argi- tinuous supply. Increasing arginine plasma levels, thereby
nine synthesis. For this reason, reduced arginine synthe- facilitating mass transport of arginine from cytosol to
sis was expected after ischemia reperfusion; however, the active sites of NOS, were shown to be beneficial in
an uptake of arginine was observed. There are several preventing an excessive release of O2 and preserved NO
possible explanations for this surprising result. First, the concentration. Since the kidney contains similar subsets
kidney is known to contain arginase [27] and activity of of enzymes as skeletal muscle [34], a fourth possible
this enzyme has been described in glomeruli in nephro- explanation for the uptake of arginine might be preven-
toxic nephritis [28]. However, activity of the enzyme tion of ischemia-reperfusion injury to the kidney. This
arginase converting arginine into ornithine, possibly ex- explanation remains highly speculative.
plaining the uptake of arginine, does not explain the To our knowledge this is the first study showing that
higher renal uptake—instead of production—of orni-
kidneys injured by ischemia-reperfusion are not capable
thine after ischemia reperfusion (Fig. 2E).
of generating arginine. This finding is clinically relevantA second possible explanation for the renal uptake of
because renal arginine synthesis is an important sourcearginine is that hypoxia induced by ischemia increases
for maintaining arginine plasma levels while the body isthe renal arginine metabolism. Elegant studies by Yu et
in a diseased state. Further investigations will be requiredal showed increased activity of the enzyme nitric oxide
to determine the exact role of decreased arginine synthe-synthase (NOS) in the proximal tubulus after hypoxia
sis in clinical conditions, but renal arginine synthesis[29]. NOS converts arginine into NO and citrulline. Here,
could contribute to the maintenance of circulating argi-reduced renal citrulline uptake after ischemia-reperfu-
nine levels at physiological values.sion was seen (Fig. 2B), possibly indicating higher NOS
That arginine plasma levels are important in clinicalactivity, and thus higher production of citrulline in the
diseased states is substantiated by a growing number ofproximal tubulus, eventually leading to diminished up-
studies. It was shown that reduced arginine plasma levelstake of renal citrulline. This possible higher activity of
may be a substrate limiting factor in saturating NOS inNOS after ischemia-reperfusion injury was confirmed in
the presence of a low dose of endotoxin, reducing blooda separate experiment (Table 5). Because the uptake of
flow to the gut significantly, an effect that was not presentarginine by the kidney was observed after ischemia re-
when arginine plasma levels were normal [35]. Traumaperfusion, irrespective the arginine plasma levels, the ef-
patients, fed an enterally glutamine-enriched diet, re-fect of ischemia-reperfusion injury on nitrate plasma and
stored arginine to physiological plasma levels and hadurine levels were studied. Although the arterial and renal
reduced infectious morbidity [10]. Supplementation ofvenous plasma levels of nitrate did not differ, urine nitrate
arginine in the surgical patient improved host immunityconcentrations were higher after ischemia-reperfusion.
[36], and reductions in morbidity in critically ill patientsAnother explanation for the arginine uptake by the
have been reported [37]. Studies by Angele et al showedkidney might be the presence of the natural occurring
that arginine supplementation not only improved intesti-methylated arginines. Methylated arginines are competi-
tive inhibitors of NOS and some of them, like asymmetric nal and thus splenic blood flow [38], but also the de-
Prins et al: Arginine flux after I/R 93
acids determined by liquid chromatography within 17 minutes.pressed splenocyte function was restored after trauma-
Clin Chem 40:245–249, 1994
hemorrhage [39]. 18. Jablonski P, Howden BO, Rae DA, et al: An experimental model
In conclusion, decreased renal arginine production is for assessment of renal recovery from warm ischemia. Transplanta-
tion 35:198–204, 1983observed with unilateral ischemia-reperfusion. This change
19. Prins HA, Houdijk APJ, van Lambalgen AA, et al: Paradoxicalin arginine flux could contribute to or slow the recovery changes in organ blood flow after arginase infusion in the non-
from the low plasma levels of arginine seen in conditions stressed rat. Shock 9:422–427, 1998
20. Langle F, Roth E, Steininger R, et al: Arginase release followinglike trauma, shock, or after vascular procedures.
liver reperfusion. Transplantation 59:1542–1549, 1995
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